Behandlingen bør ikke anvendes hos patienter med et neutrofiltal < 0, 5 x 109/ l eller et trombocyttal < 50 x 103/ μl.
In patients with an ANC < 0.5 x 109/ l or a platelet count < 50 x 103/ μ l treatment is not recommended.